Synonym
TUG-424; TUG424; TUG 424.
IUPAC/Chemical Name
3-(4-(o-tolylethynyl)phenyl)propanoic acid
SMILES Code
O=C(O)CCC1=CC=C(C#CC2=CC=CC=C2C)C=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
Preparing Stock Solutions
The following data is based on the
product
molecular weight
264.32
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Hagesaether E, Christiansen E, Due-Hansen ME, Ulven T. Mucus can change the
permeation rank order of drug candidates. Int J Pharm. 2013 Aug
16;452(1-2):276-82. doi: 10.1016/j.ijpharm.2013.05.036. Epub 2013 May 23. PubMed
PMID: 23707884.
2: Christiansen E, Due-Hansen ME, Urban C, Grundmann M, Schmidt J, Hansen SV,
Hudson BD, Zaibi M, Markussen SB, Hagesaether E, Milligan G, Cawthorne MA,
Kostenis E, Kassack MU, Ulven T. Discovery of a potent and selective free fatty
acid receptor 1 agonist with low lipophilicity and high oral bioavailability. J
Med Chem. 2013 Feb 14;56(3):982-92. doi: 10.1021/jm301470a. Epub 2013 Jan 22.
PubMed PMID: 23294321.
3: Christiansen E, Urban C, Merten N, Liebscher K, Karlsen KK, Hamacher A,
Spinrath A, Bond AD, Drewke C, Ullrich S, Kassack MU, Kostenis E, Ulven T.
Discovery of potent and selective agonists for the free fatty acid receptor 1
(FFA(1)/GPR40), a potential target for the treatment of type II diabetes. J Med
Chem. 2008 Nov 27;51(22):7061-4. doi: 10.1021/jm8010178. PubMed PMID: 18947221.